Skip to content
Recall Observatory FDA recall evidence

Drug product

Moxifloxacin Ophthalmic Solution USP 0.5%, 3 mL, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Dist. By Aurobindo Pharma USA, Inc. East Windsor, NJ 08520, NDC 72189-076-05

D-0637-2022

February 17, 2022

Class II

Product summary

Firm
Direct Rx
Event
Event 89642
Status
Terminated
Classification
Class II
Quantity
44 bottles
Official record key
drug-enforcement:D-0637-2022

Official wording

Reason: Failed impurities/degradation specifications

Code information: Lot#: 18JA2218 Exp. 6/30/23; 20DE2104 Exp. 6/30/23; 08NO2111 Exp. 6/30/23

Distribution pattern: Florida

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed impurities/degradation specifications